Retatrutid 60mg

Retatrutid is an advanced research peptide studied for its unique activity involving GLP-1, GIP, and glucagon receptor pathways. As a triple receptor agonist, it has attracted significant attention in metabolic research, including studies related to energy balance, glucose metabolism, appetite regulation, and body weight mechanisms. The 60mg specification provides researchers with a suitable quantity for laboratory analysis, peptide research, and experimental evaluation.